Microengineered cell culture systems are becoming sufficiently sophisticated that they can recapitulate many of the phenomena observed in tissues and organisms. Here, Huh and colleagues discuss the advances made in these 'organs-on-chips' and how they could be used in drug development, including target identification and validation, toxicity screening and stratified medicine.
Nature Reviews Drug Discovery.
2015;14(4):248-260. doi: 10.1038/nrd4539
Library Collection(s)